Summary
Policy briefs launched by National Cancer Society Malaysia and Boehringer Ingelheim highlights significant rates of co-existing cardiovascular, kidney, and metabolic diseases among Malaysians.
KUALA LUMPUR, June 29 The National Cancer Society of Malaysia (NCSM), in collaboration with Boehringer I…
Source: CodeBlue
AI News Q&A (Free Content)
Q1: What are the key findings from the recent policy briefs launched by the National Cancer Society Malaysia and Boehringer Ingelheim regarding cardio-renal-metabolic risk factors?
A1: The policy briefs highlight significant rates of co-existing cardiovascular, kidney, and metabolic diseases among Malaysians. The reports emphasize a high prevalence of diabetes, hypertension, and kidney disease, along with challenges such as fragmented screening pathways and disparities in care access across different states and populations.
Q2: How prevalent are cardio-renal-metabolic conditions in Malaysia, and what are the main contributing factors?
A2: Cardio-renal-metabolic conditions have a high prevalence in Malaysia, driven by factors such as obesity, insulin resistance, and sedentary lifestyles. Poor diet, characterized by high caloric and low fiber intake, along with inadequate physical activity, are significant contributors to the rising incidence of these conditions.
Q3: What does the meta-analysis on MASLD and chronic kidney disease reveal about global and regional trends?
A3: The meta-analysis reveals that metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a multisystem cardiometabolic disorder. Coexisting chronic kidney disease (CKD) in MASLD is prevalent globally, with a pooled CKD prevalence of 15.22% among individuals with MASLD. Hypertension, dyslipidemia, and diabetes are associated with higher CKD odds in this population.
Q4: What are the social determinants of health impacting cardiovascular-kidney-metabolic syndrome, according to recent studies?
A4: Social determinants of health, including economic, social, environmental, and psychosocial factors, significantly influence the progression of cardiovascular-kidney-metabolic syndrome. Factors like family history, lifestyle choices, and socio-economic status play a crucial role in disease development and management.
Q5: How does the prevalence of metabolic syndrome in Malaysia compare to other regions, and what are the implications?
A5: The prevalence of metabolic syndrome in Malaysia is around 31.4% globally, with 34.1% in upper-middle-income countries. This indicates a substantial burden and underscores the need for urgent action to manage the growing epidemic, particularly in addressing risk factors like hypertension, obesity, and diabetes.
Q6: What are the sex-specific risk factors for cardiovascular-kidney-metabolic syndrome, and how do they affect disease progression?
A6: Sex-specific risk factors include early menopause, pregnancy complications, and polycystic ovary syndrome for women, while erectile dysfunction is a risk for men. These factors can influence the progression of cardiovascular-kidney-metabolic syndrome by altering hormonal and metabolic processes.
Q7: What are the challenges in managing cardio-renal-metabolic health in Malaysia, and what solutions are proposed?
A7: Challenges include fragmented care pathways, inadequate screening, and access disparities. Proposed solutions involve integrated care models, improved public awareness, and policy interventions to enhance healthcare delivery and address the socio-economic determinants of health.
